Clinical Trial Update: Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety and efficacy of intravenous immunoglobulin for Spinocerebellar Ataxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: University of South Florida | Conditions: Spinocerebellar Ataxia | Phase 2 | Status: COMPLETED